Literature DB >> 17145611

B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells.

Mirjam van der Burg1, Corry M R Weemaes, Frank Preijers, Paul Brons, Barbara H Barendregt, Maarten J D van Tol, Peter Hoogerbrugge, Jacques J M van Dongen.   

Abstract

Severe combined immunodeficiencies (SCID) are commonly fatal early in life. Adequate diagnosis and rapid institution of treatment, such as allogeneic stem cell transplantation (SCT), is essential. Several studies demonstrated that reconstitution of B-cell function after SCT is better in B-positive SCID than in B-negative SCID. We demonstrate that B-cell reconstitution in a B-negative SCID patient due to an Artemis mutation required the elimination of the autologous precursor-B-cells in bone marrow, probably to create physical space in the precursor-B-cell niches. Apparently, occupation of the precursor-B-cell niches is a potential dominant factor influencing repopulation of a functional B-cell compartment in B-negative SCID.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145611

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  9 in total

1.  A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency.

Authors:  Hassan Abolhassani; Ning Wang; Asghar Aghamohammadi; Nima Rezaei; Yu Nee Lee; Francesco Frugoni; Luigi D Notarangelo; Qiang Pan-Hammarström; Lennart Hammarström
Journal:  J Allergy Clin Immunol       Date:  2014-07-02       Impact factor: 10.793

2.  Radiosensitive severe combined immunodeficiency disease.

Authors:  Christopher C Dvorak; Morton J Cowan
Journal:  Immunol Allergy Clin North Am       Date:  2010-02       Impact factor: 3.479

3.  Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?

Authors:  Morton J Cowan; Andrew R Gennery
Journal:  J Allergy Clin Immunol       Date:  2015-06-06       Impact factor: 10.793

4.  Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.

Authors:  Thomas R Bauer; Rima L Adler; Dennis D Hickstein
Journal:  ILAR J       Date:  2009

5.  Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.

Authors:  Neslihan Edeer Karaca; Guzide Aksu; Ferah Genel; Nesrin Gulez; Sema Can; Yesim Aydinok; Serap Aksoylar; Emin Karaca; Imren Altuglu; Necil Kutukculer
Journal:  Clin Exp Med       Date:  2009-05-21       Impact factor: 3.984

6.  A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.

Authors:  Taco W Kuijpers; Ester M M van Leeuwen; Barbara H Barendregt; Paul Klarenbeek; Daan J aan de Kerk; Paul A Baars; Machiel H Jansen; Niek de Vries; René A W van Lier; Mirjam van der Burg
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

Review 7.  Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency.

Authors:  Mirjam van der Burg; Andy R Gennery
Journal:  Eur J Pediatr       Date:  2011-04-09       Impact factor: 3.183

Review 8.  From murine to human nude/SCID: the thymus, T-cell development and the missing link.

Authors:  Rosa Romano; Loredana Palamaro; Anna Fusco; Leucio Iannace; Stefano Maio; Ilaria Vigliano; Giuliana Giardino; Claudio Pignata
Journal:  Clin Dev Immunol       Date:  2012-03-05

9.  Novel Engraftment and T Cell Differentiation of Human Hematopoietic Cells in ART -/- IL2RG -/Y SCID Pigs.

Authors:  Adeline N Boettcher; Yunsheng Li; Amanda P Ahrens; Matti Kiupel; Kristen A Byrne; Crystal L Loving; A Giselle Cino-Ozuna; Jayne E Wiarda; Malavika Adur; Blythe Schultz; Jack J Swanson; Elizabeth M Snella; Chak-Sum Sam Ho; Sara E Charley; Zoe E Kiefer; Joan E Cunnick; Ellie J Putz; Giuseppe Dell'Anna; Jackie Jens; Swanand Sathe; Frederick Goldman; Erik R Westin; Jack C M Dekkers; Jason W Ross; Christopher K Tuggle
Journal:  Front Immunol       Date:  2020-02-06       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.